Cytomed Therapeutics Ltd stock is traded at $0.85, with a volume of 370. It is down -3.41% in the last 24 hours and down -8.58% over the past month. CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Previous Close:
$0.88
Open:
$0.85
24h Volume:
370
Relative Volume:
0.03
Market Cap:
$10.14M
Revenue:
$248.40K
Net Income/Loss:
-$3.05M
P/E Ratio:
-
EPS:
-$0.2611
Net Cash Flow:
-$3.30M
1W Performance:
-7.49%
1M Performance:
-8.58%
6M Performance:
-7.61%
1Y Performance:
-58.33%
1-Day Range:
$0.85$0.85
1-Week Range:
$0.8122$0.92
52-Week Range:
$0.6801$3.10
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS